- Committed, last two years
- $655kacross 2 SBIR/STTR awards
- Most recent award
- Funding agencies
- Department of Health and Human Services, National Science Foundation
- Phases won
- Phase I
- A funded project
- “Fibroblast-derived Engineered Extracellular Vesicle (FieEV) Technology for Targeted Delivery of RNA Therapeutics to treat CMT1A Diseases”
Source: public SBIR/STTR award record, last two years. Award totals are what the government committed, not company revenue or runway; Phase II awards typically run two years.